Trials / Completed
CompletedNCT00914147
Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
Pulmonary Function Tests (PFT) in a Phase I Patient Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Barbara Ann Karmanos Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Measuring how well the lungs work in patients with cancer may help doctors predict how patients will respond to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying lung function testing in patients with locally advanced or metastatic solid tumors.
Detailed description
OBJECTIVES: Primary * To obtain the distribution of DLCO, FVC, and FEV\_1 by pulmonary function testing (PFT) in patients with heavily pretreated locally advanced or metastatic solid tumors referred to the Karmanos Cancer Institute (KCI) Phase I Clinical Trials Program. * To estimate the mean DLCO to within 4 units (% of predicted) of the true mean with 95% confidence. Secondary * To estimate the percentage of patients who meet the defined eligibility criteria (including PFT levels, especially DLCO) from the entire population enrolled in the KCI Phase I Clinical Trials Program. OUTLINE: Patients undergo pulmonary function testing comprising spirometry test, lung volumes, and DLCO measurement utilizing the single-breath breath-holding technique. Patients then proceed to treatment on a phase I clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | pulmonary function testing | After signing consent, patients will undergo a complete spirometry test, lung volumes and diffusing capacity (DLCO) measurement utilizing the single-breath breath holding technique, according to the ATS/ERS consensus and standardization. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2012-08-23
- Completion
- 2012-08-23
- First posted
- 2009-06-04
- Last updated
- 2021-03-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00914147. Inclusion in this directory is not an endorsement.